A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

NCT05865535 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AVEO Pharmaceuticals, Inc.